SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-18-023199
Filing Date
2018-09-17
Accepted
2018-09-17 15:29:04
Documents
7
Period of Report
2018-09-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K emma-8k_20180913.htm 8-K 44333
2 EX-4.1 emma-ex41_6.htm EX-4.1 107809
3 EX-4.2 emma-ex42_11.htm EX-4.2 139353
4 EX-10.1 emma-ex101_7.htm EX-10.1 282721
5 EX-10.2 emma-ex102_9.htm EX-10.2 317323
6 EX-10.3 emma-ex103_8.htm EX-10.3 87193
7 EX-10.4 emma-ex104_10.htm EX-10.4 30028
  Complete submission text file 0001564590-18-023199.txt   1010142
Mailing Address 21250 HAWTHORNE BLVD. SUITE 800 TORRANCE CA 90503
Business Address 21250 HAWTHORNE BLVD. SUITE 800 TORRANCE CA 90503 310-214-0065
EMMAUS LIFE SCIENCES, INC. (Filer) CIK: 0001420031 (see all company filings)

IRS No.: 412254389 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-53072 | Film No.: 181073320
SIC: 6770 Blank Checks